Related references
Note: Only part of the references are listed.Simultaneous detection of MCF-7 and HepG2 cells in blood by ICP-MS with gold nanoparticles and quantum dots as elemental tags
Xiaoting Li et al.
BIOSENSORS & BIOELECTRONICS (2017)
Multifunctional magnetic nanowires: A novel breakthrough for ultrasensitive detection and isolation of rare cancer cells from non-metastatic early breast cancer patients using small volumes of blood
Wooyoung Hong et al.
BIOMATERIALS (2016)
Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer
Hara Polioudaki et al.
BMC CANCER (2015)
Ex vivo and in vivo capture and deactivation of circulating tumor cells by dual-antibody-coated nanomaterials
Jingjing Xie et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Nanotechnology for enrichment and detection of circulating tumor cells
Saheel Bhana et al.
NANOMEDICINE (2015)
Detection of circulating tumor cells in non-small cell lung cancer
Annkathrin Hanssen et al.
FRONTIERS IN ONCOLOGY (2015)
Predictive factors for the presence of tumor cells in bone marrow and peripheral blood in breast cancer patients
M. Cabinakova et al.
NEOPLASMA (2015)
Quick-Response Magnetic Nanospheres for Rapid, Efficient Capture and Sensitive Detection of Circulating Tumor Cells
Cong-Ying Wen et al.
ACS NANO (2014)
Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer
Maria A. Papadaki et al.
BMC CANCER (2014)
Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer
Andreas D. Hartkopf et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of Patients with Squamous Cell Carcinoma of the Oral Cavity
Alexander Groebe et al.
CLINICAL CANCER RESEARCH (2014)
Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer
Nicola Normanno et al.
LUNG CANCER (2014)
Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients
Natalia Krawczyk et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer
N. Xenidis et al.
BRITISH JOURNAL OF CANCER (2013)
Apoptotic Circulating Tumor Cells in Early and Metastatic Breast Cancer Patients
Galatea Kallergi et al.
MOLECULAR CANCER THERAPEUTICS (2013)
CK-19 mRNA-positive cells in peripheral blood predict treatment efficacy and survival in small-cell lung cancer patients
Wei-Lin Shi et al.
MEDICAL ONCOLOGY (2013)
Circulating Tumor Cells
Vicki Plaks et al.
SCIENCE (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study
V. Georgoulias et al.
ANNALS OF ONCOLOGY (2012)
Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor
T. J. N. Hiltermann et al.
ANNALS OF ONCOLOGY (2012)
Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer
N. Androulakis et al.
BRITISH JOURNAL OF CANCER (2012)
Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
Jian-Mei Hou et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer
Tateaki Naito et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Circulating and Disseminated Tumor Cells in the Management of Advanced Prostate Cancer
Stephan Kruck et al.
ADVANCES IN UROLOGY (2012)
Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer
Jian-Mei Hou et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Detection of Circulating Tumor Cells in Human Peripheral Blood Using Surface-Enhanced Raman Scattering Nanoparticles
Xu Wang et al.
CANCER RESEARCH (2011)
Disseminated and circulating tumor cells: Role in effective cancer management
Henry Lin et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse
Emmanouil Saloustros et al.
BREAST CANCER RESEARCH (2011)
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
Galatea Kallergi et al.
BREAST CANCER RESEARCH (2011)
Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer
Shannon L. Stott et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer
A. Daskalaki et al.
BRITISH JOURNAL OF CANCER (2009)
Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer
Nikolaos Xenidis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prognostic Significance of Circulating Tumor Cells in Patients With Hormone Refractory Prostate Cancer
Takatsugu Okegawa et al.
JOURNAL OF UROLOGY (2009)
The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas
Aydanur Kargi et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2007)
Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells
Galatea Kallergi et al.
MOLECULAR MEDICINE (2007)
Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis
Kenzo Hiroshima et al.
MODERN PATHOLOGY (2006)
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database
Ramaswamy Govindan et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer
Steven J. Cohen et al.
CLINICAL COLORECTAL CANCER (2006)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer
JY Pierga et al.
BRITISH JOURNAL OF CANCER (2003)
Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: Its prognostic implication and relationship with expression of p53 and Ki-67 proteins
NH Myong
JOURNAL OF KOREAN MEDICAL SCIENCE (2003)
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer
N Xenidis et al.
ANNALS OF ONCOLOGY (2003)
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer
CA Klein et al.
LANCET (2002)
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104
M Takada et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
TTF-1 expression in pulmonary adenocarcinomas
Y Yatabe et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Immunohistochemical study of thyroid transcription factor-1 and HER2/neu in non-small cell lung cancer: Strong thyroid transcription factor-1 expression predicts better survival
AK Haque et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2002)
Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases
J Zamecnik et al.
VIRCHOWS ARCHIV (2002)
Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma
NG Ordóñez
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2000)
Share Paper
